Seminars in Hematology
Volume 44, Supplement 4 , Page S1, July 2007

Introduction: Treatment of Patients With Rituximab-Refractory Indolent Non-Hodgkin’s Lymphoma

  • Stephanie A. Gregory (Guest Editor)

      Affiliations

    • Corresponding Author InformationAddress correspondence to Stephanie A. Gregory, MD, The Elodia Kehm Professor of Medicine, Director, Section of Hematology, Rush University Medical Center/Rush University, 1725 W Harrison St, Suite 834, Chicago, IL 60612-3828.

Section of Hematology, Rush University Medical Center, Rush University, Chicago, IL

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(07)00097-2

doi:10.1053/j.seminhematol.2007.06.006

Seminars in Hematology
Volume 44, Supplement 4 , Page S1, July 2007

Article Tools